A Nevada supplement company has recalled a single lot of moringa capsules sold nationwide on Amazon after its ingredient supplier reported that FDA testing of the raw moringa leaf powder came back positive for Salmonella. No one has been reported ill from the product.
Relay Peak Research LLC, which does business as Zen Principle Naturals of Incline Village, announced the voluntary recall on July 19. It covers Zen Principle brand Moringa Capsules in 180-count plastic bottles carrying Lot A6FF4 and a best-by date of 11/2028, both printed on the bottom of the bottle. The recall applies to the single-bottle listing and the twin pack. No other Zen Principle products are affected.
That sequence is the part worth pausing on. This recall did not begin with sick customers. It began upstream, with a contaminated ingredient identified in testing and a supplier passing that result down the chain. For households that keep supplements in a cabinet for months, it is the difference between finding out now and finding out after someone in the family develops a fever and diarrhea.
A Single Lot, Caught Before Anyone Got Sick
The affected capsules were distributed nationwide from December 2025 through July 2026, sold primarily through Amazon.com and the company's own website, zenprinciple.com. The FDA notice states that one unit was sold on eBay and one on Etsy.
Buyers can identify the product by the Amazon codes as well as the lot number. The one-pack of 180 capsules carries FNSKU X000ZJJ4FT, and the 360-capsule twin pack carries FNSKU X00159YJXP.
The company said it stopped all sale and distribution of the product and is cooperating with the FDA. Consumers holding Lot A6FF4 are told to stop using it and dispose of it, and they do not need to return the bottle to receive a full refund.
Salmonella, the FDA notice states, "can cause serious and sometimes fatal infections in young children," along with frail or elderly people and those with weakened immune systems. In rare cases the bacteria can enter the bloodstream and cause more severe illness, including infected aneurysms, endocarditis and arthritis.
Because the contamination was identified in the raw material rather than through illness reports, one detail remains unresolved in the public record: whether the same supplier lot reached other finished products. The FDA has not published a finding on that question.
Supplements Reach Shelves Without Advance FDA Approval
This recall arrives well after the product had been shipping, which is the ordinary sequence for dietary supplements rather than a failure specific to this company.
Under the Dietary Supplement Health and Education Act of 1994, the FDA is, in the agency's own words, "not authorized to approve dietary supplements for safety and effectiveness before they are marketed." Manufacturers and distributors carry the legal responsibility for evaluating safety and labeling before they sell. The agency's authority to act against an adulterated or misbranded supplement generally arrives after the product is already on the market.
The FDA's consumer guidance on supplements notes that in many cases firms can lawfully introduce a supplement without even notifying the agency, and that the number of products has grown nearly twentyfold since the law passed.
Nothing in the public record indicates that Relay Peak Research failed to meet a legal requirement. The recall was voluntary, initiated after the supplier notification. The framework simply explains the timing: post-market oversight is the system's design, so recalls follow distribution by definition.
Online Buyers Face a Notification Gap
The practical problem is reaching people who already bought the product.
A shopper who buys a recalled item at a grocery chain with a loyalty card can receive a direct notification. A shopper who buys capsules through an online marketplace may or may not, depending on the platform's own processes and whether the account is still active. Amazon and other marketplaces do notify purchasers of recalled goods, but the reliability of that reaching a specific household depends on current contact details and on whether anyone opens the message.
Supplement shelf life widens the gap further. This lot carries a best-by date of November 2028. A bottle purchased in early 2026 could sit partly used in a kitchen cabinet for two more years, long after news coverage ends.
Anyone who bought moringa capsules online since December 2025 should physically check the bottom of the bottle rather than rely on memory of the brand. Checking order history on Amazon or the retailer's site is the fastest way to confirm what was purchased and when.
Symptoms and Who Faces the Most Serious Risk
Salmonella symptoms usually begin between six hours and six days after exposure and commonly include fever, diarrhea that may be bloody, nausea, vomiting and abdominal pain. Most healthy adults recover without specific treatment.
Risk is not evenly distributed. Infants and young children, adults over 65, pregnant people, and anyone whose immune system is suppressed by illness or medication face a higher chance of severe illness. Those groups should contact a clinician promptly if symptoms appear rather than waiting to see whether they pass.
Signs that warrant urgent medical evaluation include a high or persistent fever, bloody stool, diarrhea lasting more than three days, vomiting that prevents keeping liquids down, or symptoms of dehydration such as very little urination, dizziness on standing, or a dry mouth. Anyone with those symptoms should seek care without delay.
Someone who took capsules from this lot weeks ago and felt fine does not need evaluation now. Delayed illness from a past exposure is not the concern here.
This article is general information and not a diagnosis. No one should start, stop or change a prescribed medication based on a news report.
Where the Investigation Goes from Here
The broader federal investigation into Salmonella in moringa leaf powder remains active, and this is not the first product pulled over it. MedicalDaily previously reported on the multiple moringa investigations and the running list of recalled brands, which by late June covered products from several companies after an outbreak that reached 119 confirmed illnesses across 36 states. Earlier coverage traced a shared ingredient supplier linking multiple brands.
What is different this time is the trigger. Earlier recalls followed illness clusters and epidemiological interviews. This one followed a laboratory result on an ingredient, with no reported illnesses attached.
The open questions are whether the contaminated supplier lot went into other finished products, whether additional recalls follow, and whether any illnesses are eventually linked to this lot through routine surveillance. The FDA has not announced a completion date for the wider investigation.
The confirmed fact today is narrow: one lot, one brand, no reported illnesses. The people who should act are those with a Zen Principle bottle in the house, and the action is to check the bottom for Lot A6FF4 and discard it if it matches. The central uncertainty is how far the contaminated raw material traveled. Readers should rely on the FDA's recall listings rather than social media for updates.
Frequently Asked Questions
Which product is recalled?
Zen Principle brand Moringa Capsules in 180-count bottles with Lot A6FF4 and best-by date 11/2028, printed on the bottom of the bottle. It covers the single pack and the 360-capsule twin pack. No other Zen Principle products are affected.
Has anyone gotten sick from this lot?
No illnesses had been reported as of the July 19 announcement. The recall was prompted by FDA testing that found Salmonella in the moringa leaf powder used to make the lot.
Where was it sold?
Nationwide from December 2025 through July 2026, primarily through Amazon.com and zenprinciple.com, plus one unit each on eBay and Etsy.
Do I have to return the bottle for a refund?
No. The company says consumers should stop using the product and dispose of it, and do not need to return it to receive a full refund.
Who faces the greatest risk from Salmonella?
Young children, adults over 65, pregnant people and anyone with a weakened immune system face a higher chance of severe illness and should contact a clinician promptly if symptoms develop.
What symptoms should I watch for?
Fever, diarrhea that may be bloody, nausea, vomiting and abdominal pain, typically starting six hours to six days after exposure. Seek urgent care for high fever, bloody stool, diarrhea beyond three days, or signs of dehydration.
Why do supplement recalls come after products are already sold?
Under federal law, the FDA does not approve dietary supplements for safety before they are marketed. Manufacturers are responsible for safety, and the agency generally acts after a product reaches the market.
